VanEck Gold Miners ETF vs Tempus AI — how do they compare? VanEck Gold Miners ETF trades at $88.51 (market cap $25.65B), while Tempus AI trades at $70.22 (market cap $12.77B). The key difference: VanEck Gold Miners ETF is far larger — about 2× Tempus AI's market cap, and VanEck Gold Miners ETF is more actively traded (20,709,928 versus 8,980,490). Which is the better fit depends on your goals — on Pluang, investors hold VanEck Gold Miners ETF for 76 Days and Tempus AI for 22 Days on average.
| GDX | TEM | |
|---|---|---|
Market Cap | $25.65B | $12.77B |
Volume | 20,709,928 | 8,980,490 |
52-Week High | $115.84 | $99.28 |
52-Week Low | $68.28 | $41.55 |
Typical Hold Time | 76 Days | 22 Days |
Sector | — | Broad Market / Factor |
Enterprise Value | — | $13.40B |
Signals from Pluang's Aura AI — not financial advice
GDX trades at $85.46, down 3.13% today amid a bearish technical signal with 13 of 13 moving averages indicating sell signals. The ETF faces pressure from rising interest rates impacting dividend stocks and metals, with silver's sharp decline highlighting sector weakness. Recent news notes institutional selling by Allworth Financial and HB Wealth Management, though Ameritas Advisory increased its stake. Support sits at $84-$85, with resistance at $86-$87.
The outlook remains cautious due to bearish technicals and macro headwinds, but some analysts see value in gold miners' low valuations. Key risks include interest rate sensitivity and metals volatility, while potential catalysts include gold price stability and institutional accumulation. Investors should weigh technical weakness against long-term diversification benefits.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite negative profitability. Recent FDA clearance for its ECG-MR AI product and 13 abstracts accepted for ESMO Congress 2026 highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist. The stock shows strong analyst support with a $72.60 consensus target and 64% buy ratings.
Outlook remains cautiously optimistic driven by AI healthcare adoption and data licensing growth, but high valuation multiples and sustained losses pose risks. Investor sentiment is positive amid recent insider selling and institutional interest, yet profitability challenges and competitive pressures require monitoring for long-term value creation.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
The fund normally invests at least 80% of its total assets in common stocks and depositary receipts of companies involved in the gold mining industry. The index is a modified market-capitalization weighted index primarily comprised of publicly traded companies involved in the mining for gold and silver. The fund is non-diversified.
Read more on GDX →Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →